Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8

1.

Demonstrating the burden of hypoglycemia on patients' quality of life in diabetes clinical trials: measurement considerations for hypoglycemia.

Gilet H, Gruenberger JB, Bader G, Viala-Danten M.

Value Health. 2012 Dec;15(8):1036-41. doi: 10.1016/j.jval.2012.06.002. Epub 2012 Sep 8.

PMID:
23244805
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Economic burden of hypoglycemia in patients with Type 2 diabetes.

Liu S, Zhao Y, Hempe JM, Fonseca V, Shi L.

Expert Rev Pharmacoecon Outcomes Res. 2012 Feb;12(1):47-51. doi: 10.1586/erp.11.87. Review.

PMID:
22280196
4.

Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials.

Landman GW, de Bock GH, van Hateren KJ, van Dijk PR, Groenier KH, Gans RO, Houweling ST, Bilo HJ, Kleefstra N.

PLoS One. 2014 Feb 12;9(2):e82880. doi: 10.1371/journal.pone.0082880. eCollection 2014. Review.

5.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
6.

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C.

BMJ. 2011 Jul 26;343:d4169. doi: 10.1136/bmj.d4169. Review.

7.

Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery.

DeVine J, Norvell DC, Ecker E, Fourney DR, Vaccaro A, Wang J, Andersson G.

Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S69-74. doi: 10.1097/BRS.0b013e31822ef6de. Review.

PMID:
21897347
8.

Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.

Mikhail N.

Expert Opin Investig Drugs. 2008 Jun;17(6):845-53. doi: 10.1517/13543784.17.6.845 . Review.

PMID:
18491986
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk